Showing results (1301-1310 of 1,523) with videos related to

Sort By:
Pageof 153
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 27, 2011
Relative abundance of EGFR mutations predicts benefit from gefitinib treatment for advanced non-small-cell lung cancerQing Zhou, Xu-Chao Zhang, Zhi-Hong Chen, et al.
European Journal of Cancer (Oxford, England : 1990)|April 21, 2021
Clinical outcomes of non-small cell lung cancer patients with leptomeningeal metastases after immune checkpoint inhibitor treatmentsMei-Mei Zheng, Hai-Yan Tu, Jin-Ji Yang, et al.
CNS Neuroscience & Therapeutics|September 16, 2024
Autoimmune astrocytopathy double negative for AQP4-IgG and GFAP-IgG: Retrospective research of clinical practice, biomarkers, and pathologyPei-Hao Lin, Hai-Yan Yao, Li Huang, et al.
Experimental Hematology & Oncology|November 11, 2021
MET amplification identified by next-generation sequencing and its clinical relevance for MET inhibitorsLun-Xi Peng, Guang-Ling Jie, An-Na Li, et al.
Journal of Genetics and Genomics = Yi Chuan Xue Bao|November 12, 2015
Integrative Analyses of Lung Squamous Cell Carcinoma in Ten Chinese Patients with Transcriptome SequencingLu-Lu Yang, Xu-Chao Zhang, Shao-Kun Chuai, et al.
Cancer Immunology, Immunotherapy : CII|December 8, 2017
Characterization of PD-L1 expression in Chinese non-small cell lung cancer patients with PTEN expression as a means for tissue quality screeningXu-Chao Zhang, Xu Cao, Chun Sun, et al.
Lung Cancer (Amsterdam, Netherlands)|March 15, 2021
Safety and efficacy of first-line dacomitinib in Asian patients with EGFR mutation-positive non-small cell lung cancer: Results from a randomized, open-label, phase 3 trial (ARCHER 1050)Ying Cheng, Tony S Mok, Xiangdong Zhou, et al.
Pharmacoepidemiology and Drug Safety|April 2, 2022
A risk classification model for prioritising the management of quality issues relating to substandard medicines in SingaporePei San Ang, Desmond Chun Hwee Teo, Yi Long Toh, et al.
Integrative Cancer Therapies|January 22, 2025
HEalth-Related Quality of Life-Intervention in Survivors of Breast and Other Cancers Experiencing Cancer-Related Fatigue and Associated Cognitive Symptoms Using TraditionAL Chinese Medicine: The 'HERBAL' TrialAlexandre Chan, Daniella Chan, Ding Quan Ng, et al.
Thoracic Cancer|April 19, 2022
Clinical outcomes of EGFR+/METamp+ vs. EGFR+/METamp- untreated patients with advanced non-small cell lung cancerKai-Cheng Peng, Jun-Wei Su, Zhi Xie, et al.
Pageof 153